News tagged ‘BasicResearch’ clear
- Dana-Farber scientists and colleagues have published results from the Cancer Cell Line Encyclopedia, a resource that marries cancer genome data with predictors of drug responses. This information could refine cancer clinical trials and future treatments.
Tags: BasicResearch, Genomics
- Dana-Farber researchers are studying melanoma tumors' microenvironments to better understand how some melanoma continue to grow and survive despite the presence of anti-cancer drugs.
Tags: BasicResearch, Genomics, Melanoma
- A therapy involving a natural compound may improve the ability of stem cells from umbilical cord blood to engraft in patients receiving a stem cell transplant for cancer or other diseases.
Tags: BasicResearch, StemCellTransplant
- A study led by researchers at Dana-Farber Cancer Institute and Broad
Institute of the Massachusetts Institute of Technology and Harvard
University provides the first demonstration of a practical method of
screening tumors for cancer-related gene abnormalities that might be
treated with "targeted" drugs.
Tags: BasicResearch, Genomics, Genetics
- A study documents the connection between increased levels of epoxyeicosatrienoic acids (EET) lipids and cancer growth and metastasis opening the door to a new avenue for cancer treatment.
- Dana-Farber scientists have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins to which the cancers are "addicted."
Tags: BasicResearch, BreastCancer, Leukemia
- Dana-Farber researchers find that physicians surveyed advise against
private blood banking of umbilical cord blood unless another family
member is at risk for a blood disease.
- Dana-Farber and Broad Institute researchers for the first time are able to show the past, present, and future of CLL tumors.
Tags: BasicResearch, Genetics, Leukemia
- Research shows ability to damage cancer cell DNA and prevent cells from
initiating a rest-and-repair process, causing them to self-destruct.
Showing 1-10 of 115 items